479 related articles for article (PubMed ID: 31499171)
1. Design and characterization of a novel 3D printed pressure-controlled drug delivery system.
Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W
Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171
[TBL] [Abstract][Full Text] [Related]
2. Controlled Release of 5-Fluorouracil from Alginate Beads Encapsulated in 3D Printed pH-Responsive Solid Dosage Forms.
Gioumouxouzis CI; Chatzitaki AT; Karavasili C; Katsamenis OL; Tzetzis D; Mystiridou E; Bouropoulos N; Fatouros DG
AAPS PharmSciTech; 2018 Nov; 19(8):3362-3375. PubMed ID: 29948989
[TBL] [Abstract][Full Text] [Related]
3. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
5. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.
Linares V; Casas M; Caraballo I
Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539
[TBL] [Abstract][Full Text] [Related]
6. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
7. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
8. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.
Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW
Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468
[TBL] [Abstract][Full Text] [Related]
11. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
12. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
13. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
14. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
[TBL] [Abstract][Full Text] [Related]
16. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
17. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
18. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals.
Deshkar S; Rathi M; Zambad S; Gandhi K
Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646
[TBL] [Abstract][Full Text] [Related]
19. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
20. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
